Article Versions Notes

Cavalli E, Mazzon E, Basile MS, Mammana S, Pennisi M, Fagone P, Kalfin R, Martinovic V, Ivanovic J, Andabaka M, et al. In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod. Molecules. 2020; 25(1):20. https://doi.org/10.3390/molecules25010020

Cavalli, Eugenio, Emanuela Mazzon, Maria Sofia Basile, Santa Mammana, Manuela Pennisi, Paolo Fagone, Reni Kalfin, Vanja Martinovic, Jovana Ivanovic, Marko Andabaka, and et al. 2020. "In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod" Molecules 25, no. 1: 20. https://doi.org/10.3390/molecules25010020

Cavalli, E., Mazzon, E., Basile, M. S., Mammana, S., Pennisi, M., Fagone, P., Kalfin, R., Martinovic, V., Ivanovic, J., Andabaka, M., Mesaros, S., Pekmezovic, T., Drulovic, J., Nicoletti, F., & Petralia, M. C. (2020). In Silico and In Vivo Analysis of IL37 in Multiple Sclerosis Reveals Its Probable Homeostatic Role on the Clinical Activity, Disability, and Treatment with Fingolimod. Molecules, 25(1), 20. https://doi.org/10.3390/molecules25010020